[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351031-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-351031-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","ax-2-a-promising-non-hemolytic-protein-of-bacillus-thuringiensis-with-potent-selective-cytotoxicity-against-breast-cancer-cells","AX-2 - A Promising Non-Hemolytic Protein of Bacillus thuringiensis with Potent Selective Cytotoxicity Against Breast Cancer Cells","","Conventional cancer therapies often damage healthy tissues due to limited specificity, causing adverse effects that reduce patients’ quality of life. Parasporins, non-hemolytic parasporal proteins from Bacillus thuringiensis, show selective cytotoxicity against cancer cells but are commonly tested only after physical/biochemical activation and peptide fragmentation. This study proposes a purification method that isolates protein without prior activation and evaluates its cytotoxic mechanism. From the B. thuringiensis AX isolate, AX-2 uniquely kills MCF-7 breast cancer cells while remaining non-hemolytic and non-toxic to normal cells, inducing apoptosis without oxidative stress and with cell death initiating at the plasma membrane.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/ax-2-a-promising-non-hemolytic-protein-of-bacillus-thuringiensis-with-potent-selective-cytotoxicity-against-breast-cancer-cells/351031/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/ax-2-a-promising-non-hemolytic-protein-of-bacillus-thuringiensis-with-potent-selective-cytotoxicity-against-breast-cancer-cells/351031.png","ImageObject",300,407,{"name":42,"@type":43},"Ezra","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address in conventional cancer therapy?","Question",{"text":63,"@type":64},"Conventional therapies often harm healthy tissues because of poor specificity, leading to significant side effects and reduced quality of life.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does the proposed approach differ from typical parasporin testing?",{"text":68,"@type":64},"Instead of activating and fragmenting proteins into peptide mixtures, the study purifies the target protein without prior activation and then evaluates cytotoxicity and mechanism.",{"name":70,"@type":61,"acceptedAnswer":71},"What are the key properties of AX-2 in this work?",{"text":72,"@type":64},"AX-2 shows cytotoxic activity against MCF-7 breast cancer cells while remaining non-hemolytic and non-toxic to normal cells, and it induces apoptosis without oxidative stress.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},351031,1791084793,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Article  \nAX-2: A Promising Non-Hemolytic Protein of Bacillus thuringiensis with Potent Selective Cytotoxicity Against Breast Cancer Cells  \nAlain Cruz-Nolasco 1, Miguel Angel Peña-Rico 2, *, Sibel J. Estrada-Escobedo 3, Angel A. Ortela-Gregorio 3, Erick A. Juarez-Arellano 4, Genaro Vázquez-Victorio 5, Angelica S. Martinez-Ramirez 2,  \nMichele Rorato Sagrillo 6, Roberto C. Vianna Santos 7, Luz Camacho 8, Nayeli G. Nieto-Velázquez 9 and A. Karin Navarro-Mtz 2, *  \nAcademic Editor: Ian Edwin Cock  \nReceived: 22 November 2025  \nRevised: 9 January 2026  \nAccepted: 19 January 2026  \nPublished: 29 January 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 División de Estudios de Posgrado, Doctorado en Biotecnología, Universidad del Papaloapan, Circuito Central  \n200, Parque Industrial, Tuxtepec 68301, Oaxaca, Mexico; [alandurst13@gmail.com](alandurst13@gmail.com)  \n2 Centro de Investigaciones Científicas, Instituto de Biotecnología, Universidad del Papaloapan, Circuito Central 200, Parque Industrial, Tuxtepec 68301, Oaxaca, Mexico; [asmartinez@unpa.edu.mx](asmartinez@unpa.edu.mx)  \n3 División de Estudios de Posgrado, Maestría en Biotecnología, Universidad del Papaloapan, Circuito Central  \n200, Parque Industrial, Tuxtepec 68301, Oaxaca, Mexico  \n4 Centro de Investigaciones Científicas, Instituto de Química Aplicada, Universidad del Papaloapan, Circuito Central 200, Parque Industrial, Tuxtepec 68301, Oaxaca, Mexico; [eajuarez@unpa.edu.mx](eajuarez@unpa.edu.mx)  \n[5](5 Facultad de Ciencias)[ Facultad de Ciencias](5 Facultad de Ciencias), [Universidad Nacional Aut](Universidad Nacional Aut)ó[noma de M](noma de M)é[xico](xico), [Circuito Exterior S/N](Circuito Exterior S/N), [Ciudad](Ciudad)[ ](Ciudad)Universitaria, Ciudad de Mexico 04510, Mexico  \n6 Graduate Program in Nanoscience, Franciscan University, Santa Maria 97010-032, RS, Brazil  \n7 Oral Microbiology Laboratory, Universidade Federal de Santa Maria, Santa Maria 97065-060, RS, Brazil  \n8 Laboratorio de Nutrición Experimental, Instituto Nacional de Pediatría, Ciudad de Mexico 04530, Mexico  \n9 División de Investigación, Hospital Juárez de México, Ciudad de Mexico 07760, Mexico  \n* [Correspondence: mapena@unpa.edu.mx](Correspondence: mapena@unpa.edu.mx) (M.A.P.-R.); [anavarro@unpa.edu.mx](anavarro@unpa.edu.mx) (A.K.N.-M.); Tel.: +52-287-875-9240 (ext. 220) (M.A.P.-R. & A.K.N.-M.)  \nAbstract  \nConventional cancer therapies often harm healthy tissues due to their poor specificity, resulting in significant side effects that diminish patients’ quality of life. Parasporins, a group of non-hemolytic parasporal proteins produced by Bacillus thuringiensis, are known for their selective cytotoxicity toward cancer cells. Typically, these proteins require activation through physical or biochemical treatments that fragment them into multiple peptides of varying sizes, which are then tested as mixtures, without purification, against cancer cell lines. In this study, a purification strategy that isolates the protein without prior activation and evaluates the resulting cytotoxic mechanism is proposed. The purification consists of four steps: (1) crystal solubilization with Laemmli buffer,(2) size-based separation via SDS-PAGE, (3) electroelution of the target protein from the gel, and (4) dialysis to remove the elution buffer. From the B. thuringiensis AX isolate, four proteins ranging from ~20 to 60 kDa were recovered, but only AX-2 displayed cytotoxic activity toward MCF-7 breast cancer cells, while remaining non-hemolytic and non-toxic to normal cells (erythrocytes, PBMCs, and MRC-5 fibroblasts) . Thus, AX-2 qualifies as a parasporin. AX-2 induces apoptosis in MCF-7 breast cancer cells without generating oxidative stress, and the observed cell death appears to initiate at the plasma membrane rather than through intracellular pathwa","cbCaij8OU2H3iaY9","https://ap.wps.com/l/cbCaij8OU2H3iaY9","pdf",3481998,25,"English","# Introduction\n# Materials and Methods\n# Results\n# Discussion","[{\"question\":\"What problem does the study address in conventional cancer therapy?\",\"answer\":\"Conventional therapies often harm healthy tissues because of poor specificity, leading to significant side effects and reduced quality of life.\"},{\"question\":\"How does the proposed approach differ from typical parasporin testing?\",\"answer\":\"Instead of activating and fragmenting proteins into peptide mixtures, the study purifies the target protein without prior activation and then evaluates cytotoxicity and mechanism.\"},{\"question\":\"What are the key properties of AX-2 in this work?\",\"answer\":\"AX-2 shows cytotoxic activity against MCF-7 breast cancer cells while remaining non-hemolytic and non-toxic to normal cells, and it induces apoptosis without oxidative stress.\"}]","AX-2 - A Promising Non-Hemolytic Protein of Bacillus thuringiensis with Potent Selective Cytotoxicity Against Breast Cancer Cells | PDF",1790092337,63,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4c01282adf277cb2065d8bc6f3155a3b.webp",983,1390,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da666be9d5c6188226d4f021bb512fdf.webp",982,1388,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1047840e5ad0c5e6b04d13e498bb94d9.webp",981,1387,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a9bc0b4b3e2ecff377c0873c23579a4a.webp",980,1385]